Physician profile
Jon C Walsh
NPI 1932210713
$586.45
in general payments reported to CMS, 2019-2025
9 companies · $49.69 in 2025
The $49.69 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.69 · 2022: $175 · 2023: $18.92 · 2024: $286 · 2025: $49.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.76 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $175.00 | 2022 | |
| Abbvie INC. | $122.56 | 2024 | |
| Smith+Nephew, INC. | $102.25 | 2019-2025 | Collagenase Santyl, Acticoat 4" X 4", Stravix |
| Medtronic, INC. | $65.21 | 2024 | Situate |
| Csl Behring | $36.37 | 2024 | Kcentra |
| Boston Scientific Corporation | $24.29 | 2025 | Watchman Access System |
| Polarityte, INC. | $21.18 | 2019 | |
| Melinta Therapeutics, LLC | $20.67 | 2019 | |
| Bioventus LLC | $18.92 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.